Disease/Infection News

RSS

Koronis' KP-1461 drug causes extra mutations to occur in HIV genome in HIV-infected patients

Recently published Phase 2a clinical trial results show that the frequency of specific, drug-induced mutations in the HIV genome can be significantly increased by administering KP-1461, a drug being developed by Koronis Pharmaceuticals based on its novel Viral Decay Acceleration (VDA) drug mechanism.

20 Jan 2011

Swiss HIV Cohort Study identifies simple method to determine time of infection

Identifying the time of HIV infection. Researchers of the Swiss HIV Cohort Study have identified a simple method to establish when a patient contracted the virus causing . The time of infection can be of importance for the treatment of the illness and it contributes to the understanding of the course of the epidemic.

20 Jan 2011

UMB enters license agreement with Bali BioSciences for new strategy to combat sepsis, HIV/AIDS

The University of Maryland, Baltimore's (UMB) Office of Technology Transfer has completed a license agreement with Bali BioSciences LLC, an early-stage company pursuing an unusual, yet clever, strategy to combat disease.

20 Jan 2011

QBC Diagnostics releases ParaLens Advance to provide benefits of LED fluorescence microscopy

QBC Diagnostics is pleased to announce the release of the QBC ParaLens Advance, a breakthrough product that can easily upgrade any compound light microscope for LED fluorescence microscopy.

20 Jan 2011

DARPA grants $5.6 million to Dana-Farber to develop viable countermeasures against unknown pathogen

Researchers at Dana-Farber Cancer Institute have received a $5.6 million grant from the Defense Advanced Research Projects Agency and the Army Research Office to develop transient immunity against known, unknown, naturally occurring, or engineered disease-causing pathogens.

20 Jan 2011

World Bank announces additional $5m grant to fight cholera in Haiti

The World Bank on Tuesday "announced a $15 million grant to Haiti to fight a persistent cholera epidemic," SAPA/Health24 reports. In a press release, the bank said it approved an additional $5 million to be added to a previously announced $10 million grant. "The funds, said the organisation in [the] statement, will go towards public campaigns to prevent infection and increase the capacity of Haiti's health ministry to deal with the emergency," the news service writes (1/19).

20 Jan 2011

WHO Director-General expresses concern over public mistrust of vaccines

During the WHO's executive board meeting Monday, WHO Director-General Margaret Chan expressed concerns over what she called a "'worrisome' public mistrust of vaccines, following signs of a tail-off in flu vaccination," Agence France-Presse reports (1/18).

20 Jan 2011

Exciton, ULURU sign agreement to develop and market Altrazeal exSALT product

ULURU Inc. announced today that it has signed a Binding Letter of Intent with Exciton Technologies Inc. to develop and market a product that will combine Altrazeal® with Exciton's proprietary exSALT™ Antimicrobial Technology.

20 Jan 2011

Apricus Bio's MycoVa demonstrates 'non-inferiority' for treatment of onychomycosis compared to Loceryl

Apricus Biosciences, Inc. today announced that an additional analysis conducted on behalf of the Company has shown that MycoVa™ has successfully demonstrated 'non-inferiority' for the treatment of onychomycosis (commonly referred to as nail fungus), compared to the current standard of care in Europe for topical therapy, Loceryl®.

20 Jan 2011

Small molecules may inhibit entry of Ebola into human cells

Ebola, a virus that causes deadly hemorrhagic fever in humans, has no known cure or vaccine. But a new study by University of Illinois at Chicago scientists has uncovered a family of small molecules which appear to bind to the virus's outer protein coat and may inhibit its entry into human cells.

20 Jan 2011

Study: HIV-positive head and neck cancer patients respond well to radiation therapy treatments

HIV-positive head and neck cancer patients respond well to radiation therapy treatments and experience similar toxicity rates as non-HIV-positive patients, despite prior reports to the contrary, according to a study in the January issue of the International Journal of Radiation Oncology•Biology•Physics, an official journal of the American Society for Radiation Oncology.

19 Jan 2011

Scientists determine protein structure that delivers genetic material of HIV to human cells

A team of scientists at The Scripps Research Institute and the University of Virginia has determined the structure of the protein package that delivers the genetic material of the human immunodeficiency virus to human cells.

19 Jan 2011

Study finds link between public transport and risk of catching ARI

You are six times more likely to end up at the doctors with an acute respiratory infection if you have recently used a bus or tram — but those who use buses or trams daily might well be somewhat protected compared with more occasional users.

19 Jan 2011

Legionnaires’ disease scare in Bali: Australian tourists warned

Commonwealth chief medical officer Jim Bishop has warned Australians who have returned from Bali on an outbreak of Legionnaires’ disease on the popular Indonesian resort island. The Australian health authorities knew of 11 cases of Legionnaires’ disease detected in Victorians and Western Australians after holidays in the Kuta area of Bali between August 2010 and January 2011.

19 Jan 2011

Malaria parasite caught in action on film for the first time

Australian researchers have managed to take pictures of microscopic malaria parasite as it invades a human red blood cell. This will provide a deeper understanding of the parasite’s behaviour and may help fight it. Up to 10% of the world’s population contract malaria every year and a million people, mostly pregnant women and children, die as a result of the parasite transmitted by infected mosquitoes.

19 Jan 2011

Race and region play major role in health outcomes of people infected with HIV

Women, nonwhites, and people in the southern United States who were newly infected with HIV and followed for an average of four years experienced greater HIV/AIDS-related morbidity compared to men and people of other races living in other regions of the country. The findings, published in the February 15 issue of The Journal of Infectious Diseases, underscore the urgent need to improve the health of these populations in order to reduce HIV-related morbidity and mortality in the U.S.

19 Jan 2011

Transplant surgeons routinely use fewer organs from high-risk donors

As a response to a 2007 episode in which four patients in Chicago were transplanted with organs from a single donor unknowingly infected with HIV — the only such episode in 20 years — one-third of transplant surgeons in the United States "overreacted" and began routinely using fewer organs from high-risk donors, new research from Johns Hopkins finds.

19 Jan 2011

Collaborative study may lead to improved influenza vaccine and vaccines for other respiratory virus infections

A collaborative project between researchers at the Trudeau Institute and their colleagues at St. Jude Children's Research Hospital in Memphis, Tenn., offers new insights that may lead to an improved strategy to protect against the influenza virus and other viruses that infect the respiratory tract.

19 Jan 2011

Dr. Kathleen receives NSF grant to measure how climate change will impact risk of malaria, dengue fever

Thanks to a $250,000 National Science Foundation grant we may soon know how climate change will impact our risk of malaria and dengue fever. Dr. Kathleen Schreiber, professor of geography at Millersville University of Pennsylvania, received the grant from the NSF sponsored Vector-Borne Disease Project to measure how environmental temperature change influences the transmission and disease risk of the two diseases.

19 Jan 2011

Dextran-coated onto iron oxide nanoparticles can detect cholera toxin: Study

A complex sugar may someday become one of the most effective weapons to stop the spread of cholera, a disease that has claimed thousands of lives in Haiti since the devastating earthquake last year.

19 Jan 2011

Disease/Infection News

Koronis' KP-1461 drug causes extra mutations to occur in HIV genome in HIV-infected patients

Swiss HIV Cohort Study identifies simple method to determine time of infection

UMB enters license agreement with Bali BioSciences for new strategy to combat sepsis, HIV/AIDS

QBC Diagnostics releases ParaLens Advance to provide benefits of LED fluorescence microscopy

DARPA grants $5.6 million to Dana-Farber to develop viable countermeasures against unknown pathogen

World Bank announces additional $5m grant to fight cholera in Haiti

WHO Director-General expresses concern over public mistrust of vaccines

Exciton, ULURU sign agreement to develop and market Altrazeal exSALT product

Apricus Bio's MycoVa demonstrates 'non-inferiority' for treatment of onychomycosis compared to Loceryl

Small molecules may inhibit entry of Ebola into human cells

Study: HIV-positive head and neck cancer patients respond well to radiation therapy treatments

Scientists determine protein structure that delivers genetic material of HIV to human cells

Study finds link between public transport and risk of catching ARI

Legionnaires’ disease scare in Bali: Australian tourists warned

Malaria parasite caught in action on film for the first time

Race and region play major role in health outcomes of people infected with HIV

Transplant surgeons routinely use fewer organs from high-risk donors

Collaborative study may lead to improved influenza vaccine and vaccines for other respiratory virus infections

Dr. Kathleen receives NSF grant to measure how climate change will impact risk of malaria, dengue fever

Dextran-coated onto iron oxide nanoparticles can detect cholera toxin: Study

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Latest News